SG11202107821RA - Drug delivery system - Google Patents

Drug delivery system

Info

Publication number
SG11202107821RA
SG11202107821RA SG11202107821RA SG11202107821RA SG11202107821RA SG 11202107821R A SG11202107821R A SG 11202107821RA SG 11202107821R A SG11202107821R A SG 11202107821RA SG 11202107821R A SG11202107821R A SG 11202107821RA SG 11202107821R A SG11202107821R A SG 11202107821RA
Authority
SG
Singapore
Prior art keywords
delivery system
drug delivery
drug
delivery
Prior art date
Application number
SG11202107821RA
Inventor
Cogan Felicity De
Anna Peacock
Naa Dei Nikoi
Original Assignee
Univ Birmingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Birmingham filed Critical Univ Birmingham
Publication of SG11202107821RA publication Critical patent/SG11202107821RA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202107821RA 2019-01-18 2020-01-20 Drug delivery system SG11202107821RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1900728.5A GB201900728D0 (en) 2019-01-18 2019-01-18 Drug delivery system
PCT/GB2020/050108 WO2020148556A1 (en) 2019-01-18 2020-01-20 Drug delivery system

Publications (1)

Publication Number Publication Date
SG11202107821RA true SG11202107821RA (en) 2021-08-30

Family

ID=65528247

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202107821RA SG11202107821RA (en) 2019-01-18 2020-01-20 Drug delivery system

Country Status (12)

Country Link
US (1) US20220125926A1 (en)
EP (1) EP3911300B1 (en)
JP (1) JP2022523289A (en)
KR (1) KR20210133217A (en)
CN (1) CN113329735A (en)
AU (1) AU2020208816A1 (en)
BR (1) BR112021014115A2 (en)
CA (1) CA3126888A1 (en)
GB (1) GB201900728D0 (en)
SG (1) SG11202107821RA (en)
WO (1) WO2020148556A1 (en)
ZA (1) ZA202105940B (en)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1304122A2 (en) * 1997-05-21 2003-04-23 The Board Of Trustees Of The Leland Stanford Junior University Composition and method for enhancing transport across biological membrane
JP2002502376A (en) * 1997-05-21 2002-01-22 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ Compositions and methods for enhancing transport across biological membranes
US8241670B2 (en) * 2004-04-15 2012-08-14 Chiasma Inc. Compositions capable of facilitating penetration across a biological barrier
US20110053829A1 (en) * 2009-09-03 2011-03-03 Curevac Gmbh Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
WO2011132826A1 (en) * 2010-04-19 2011-10-27 Snu R&Db Foundation Transdermal drug delivery system and pharmaceutical composition for preventing or treating bone diseases
MX2012012743A (en) * 2010-05-03 2012-11-23 Genentech Inc Compositions and methods useful for reducing the viscosity of protein-containing formulations.
JP2015515282A (en) * 2012-04-25 2015-05-28 エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント Compositions and methods for wound healing and tissue repair
AU2014229557B2 (en) * 2013-03-13 2017-12-07 Anteis Sa Peptides for skin rejuvenation and methods of using the same
GB201401453D0 (en) 2014-01-28 2014-03-12 Univ Birmingham Transmucosal and transepithelial drug delivery system
EP3419588B1 (en) * 2016-02-22 2023-04-05 Outplay Inc. Composition for topical use based on a carnosine-magnesium complex
CA3042740A1 (en) * 2016-11-21 2018-05-24 Vivier Canada Inc. Putrescine slow-release topical formulations
EP3654941A1 (en) * 2017-07-17 2020-05-27 Keith Roizman Topical delivery of therapeutic agents comprising cell-penetrating peptides for use for the treatment of age-related macular degeneration and other eye diseases

Also Published As

Publication number Publication date
CA3126888A1 (en) 2020-07-23
JP2022523289A (en) 2022-04-22
BR112021014115A2 (en) 2021-09-21
ZA202105940B (en) 2023-04-26
WO2020148556A1 (en) 2020-07-23
EP3911300A1 (en) 2021-11-24
US20220125926A1 (en) 2022-04-28
KR20210133217A (en) 2021-11-05
EP3911300B1 (en) 2024-04-17
CN113329735A (en) 2021-08-31
AU2020208816A1 (en) 2021-08-12
GB201900728D0 (en) 2019-03-06

Similar Documents

Publication Publication Date Title
IL291155A (en) Drug delivery device
IL291004A (en) Drug delivery device
IL276784A (en) Drug delivery systems
IL291415A (en) Drug delivery device
IL291295A (en) Drug delivery device
IL272278A (en) Local disinfection for drug delivery system
IL291154A (en) Drug delivery device
GB201807040D0 (en) Drug delivery
IL274920A (en) Maytansinoid-based drug delivery systems
GB202004701D0 (en) Delivery system
GB201907302D0 (en) Delivery system
IL280184A (en) Drug delivery devices
GB202008130D0 (en) Delivery system
IL291283A (en) Drug delivery formulations
IL275664A (en) Drug delivery system
EP3888693A4 (en) Drug delivery system using solution
GB202004730D0 (en) Delivery system
GB202004702D0 (en) Delivery system
GB202004707D0 (en) Delivery system
GB2570113B (en) Ocular drug delivery system
ZA202105940B (en) Drug delivery system
GB201916884D0 (en) Nanoparticle-like delivery system
GB202113045D0 (en) Delivery System
GB202110541D0 (en) Delivery system
GB202110546D0 (en) Delivery system